All Things Considered
Mon - Fri 4-7 p.m., Sat - Sun 5-6 p.m.
All Things Considered brings listeners the biggest stories of the day, thoughtful commentaries, insightful features on the quirky and the mainstream in arts and life, music and entertainment, all brought alive through sound.
All Things Considered is the most listened-to, afternoon drive-time, news radio program in the country. The program has earned many of journalism's highest honors, including the George Foster Peabody Award, the Alfred I. duPont-Columbia University Award and the Overseas Press Club Award.
Latest Episodes
-
The Supreme Court heard arguments Wednesday on birthright citizenship at a key political moment for President Trump.
-
On April 1, 2001, a midair collision between an American aircraft and a Chinese plane sparked an 11-day diplomatic crisis — and the two countries still tell very different stories.
-
NPR's Scott Detrow speaks with international law expert Gabor Rona about attacks on civilian infrastructure in the Iran conflict and how they may constitute war crimes.
-
The Supreme Court's decision outlawing bans on conversion therapy will change the legal situation in many states. An evangelical Christian therapist and LGBTQ activist share how people are responding.
-
What are the implications for the oil market and the broader global economy if the Strait of Hormuz remains largely closed for months?
-
New federal data shows American farmers are planting millions fewer acres of corn and wheat in response to much higher fertilizer prices since the U.S. attacked Iran.
-
NASA is preparing to launch four people on a trip around the moon and back. It's the first time in more than a half-century humans are set to venture around the moon.
-
Amidst conflicting signals from the White House on the war in Iran, the president addresses the nation Wednesday on the conflict.
-
NPR's Scott Detrow speaks with Shane Littrell of Cornell University, whose new study concludes that those who buy into corporate jargon may actually be worse at their jobs.
-
The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form of Wegovy as an alternative to obesity drugs given by injection.
